Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Deficits in the IgG+ memory B‐cell recovery after anthracycline treatment is confined to the spleen of rhesus macaques
Stockholm University, Faculty of Science, Department of Molecular Biosciences, The Wenner-Gren Institute.
Show others and affiliations
Number of Authors: 122020 (English)In: Clinical & Translational Immunology (CTI), E-ISSN 2050-0068, Vol. 9, no 7, article id e1150Article in journal (Refereed) Published
Abstract [en]

Objectives. Loss of vaccine-induced antibodies (Abs) after chemotherapy against paediatric acute lymphoblastic leukaemia (ALL) is common and often necessitates re-immunisation after cessation of treatment. Even so, some ALL survivors fail to mount or to maintain protective Abs. Germinal centres (GCs) are clusters of proliferating B cells in follicles of secondary lymphoid tissues (SLTs) formed during adaptive immune responses and the origins of long-lived memory B and plasma cells that are the source of Abs. Furthermore, productive GC reactions depend on T follicular helper (TFH) cells. To understand why chemotherapy induces deficits in Ab responses, we examined how SLTs were affected by chemotherapy. Methods. Rhesus macaques were infused with either three cycles of the anthracycline doxorubicin or saline, followed by immunisation with a de novo and booster antigen. Spleen and lymph nodes were removed, and memory B, bulk T and TFH cells were examined. Results. Despite adequate GC morphology, a diminished memory and IgG+ B-cell population along with diminished total and booster vaccine-specific IgGproducing memory B cells were noted in the spleens of macaques with past doxorubicin exposure compared to the saline-treated controls (P < 0.05). Intact bulk T and TFH cells were found in the SLTs of treated macaques, which displayed higher CD40L upregulation capacity by their splenic CXCR5+ helper T cells (P < 0.01). In contrast to the spleen, the immune cell populations studied were comparable between the lymph nodes of both saline- and doxorubicin-treated macaques. Conclusion. Our findings suggest that the splenic memory B-cell subset, compared to its lymph node counterpart, is more severely altered by anthracycline treatment.

Place, publisher, year, edition, pages
2020. Vol. 9, no 7, article id e1150
Keywords [en]
anthracycline, de novoand booster vaccine, memory B-cell response, rhesus macaque, secondary lymphoid organs
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:su:diva-186197DOI: 10.1002/cti2.1150ISI: 000556914500013PubMedID: 32642064OAI: oai:DiVA.org:su-186197DiVA, id: diva2:1480021
Available from: 2020-10-27 Created: 2020-10-27 Last updated: 2022-12-09Bibliographically approved
In thesis
1. Functions and memory features of adaptive- and innate immune cells in physiological and inflammatory settings
Open this publication in new window or tab >>Functions and memory features of adaptive- and innate immune cells in physiological and inflammatory settings
2022 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

The immune system is a complex but well-regulated network which cooperates with the microbiota to maintain optimal homeostasis under physiological settings. A number of factors display the capacity to alter the immune system and thus microbiota crosstalk including host genetics, diet, environmental influences and drugs such as antibiotics or chemotherapeutic agents.

We and others have previously demonstrated immune regulatory capacities of the gut commensal Limosilactobacillus reuteri (L. reuteri) that seem to act via myeloid cells. In paper I, we have further shown that priming of blood dendritic cells (DCs) or monocytes with L. reuteri-derived cell free supernatant (CFS) modifies how these cells respond to future stimulus challenge, even after monocytes differentiation to DCs (mo-DCs). Notably, priming conditions in mo-DCs skewed subsequent T-helper cell responses. In paper II, we continued to elaborate on whether microbial and gut-associated metabolites modify chemotherapy-induced effects. Thus far, we could show that the CFS from probiotic bacteria might imprint immune cells to modulate inflammatory responses when intestinal epithelial cells are compromised by chemotherapy exposure. In paper III, we investigated how chemotherapy agent Doxorubicin (Doxo) affects bone marrow resident mesenchymal stromal cells (BM MSCs) which support antibody secreting cells (ASCs) responsible for serological memory. Our findings have shown that Doxo-induced alterations in BM MSCs are not sufficient to disrupt their support to ASCs, thus alternative or additional factors might be implicated in ASC preservation during chemotherapy. Lastly, in paper IV, we investigated how Doxo affects secondary lymphoid organs and we found that splenic compartment is more prominently affected by Doxo treatment compared to its lymph node counterpart in an animal model of rhesus macaques.

Collectively, this thesis outlines novel perceptions on innate immune memory-like capacity and how gut-associated factors influence such recall responses in innate immune cells. Further, this thesis increases our knowledge on how adaptive immune cells, required for long-term serological memory, are preserved during toxic conditions such as those induced by chemotherapy treatment.

Place, publisher, year, edition, pages
Stockholm: Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 2022. p. 77
Keywords
Innate immune memory, Limosilactobacillus reuteri, dendritic cells, lymphocytes, cytokines, immunological memory, intestinal epithelial cells, chemotherapy, bone marrow, secondary lymphoid organs
National Category
Immunology
Research subject
Molecular Bioscience
Identifiers
urn:nbn:se:su:diva-204457 (URN)978-91-7911-840-2 (ISBN)978-91-7911-841-9 (ISBN)
Public defence
2022-08-26, Vivi Täckholmsalen (Q-salen), NPQ-huset, Svante Arrhenius väg 20, Stockholm, 09:00 (English)
Opponent
Supervisors
Available from: 2022-06-01 Created: 2022-05-09 Last updated: 2022-05-19Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Lasaviciute, GintareSverremark-Ekström, Eva

Search in DiVA

By author/editor
Lasaviciute, GintareSverremark-Ekström, Eva
By organisation
Department of Molecular Biosciences, The Wenner-Gren Institute
In the same journal
Clinical & Translational Immunology (CTI)
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 43 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf